Skip to main content

Table 2 Clinical and biological characteristics of the non-SVR and SVR groups

From: Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infection

  non-SVR (n = 64) SVR (n = 30) P value
Age, yearsa 69 (21–85) 72 (57–87) 0.60
Gender (male/female) 46/18 23/7 0.12
Plt (×103/μl)a 14.2 (3.1–31.0) 12.7 (7.2–34.6) 0.30
BMI (kg/m2)a 21.5 (18.5–33.5) 22.5 (18.9–30.2) 0.65
Alb (g/dl)a 4.1 (2.8–5.1) 4.1 (3.0–4.9) 1.00
T-Bil (mg/dl)a 0.7 (0.3–2.9) 0.8 (0.3–2.7) 0.91
AST (U/L)a 36.5 (14–114) 33.5 (13–66) 0.07
ALT (U/L)a 30.9 (9–114) 25.5 (11–45) 0.08
M2BPGi (COI)a 2.79 (0.29–8.75) 2.37 (0.42–8.60) 0.70
FIB-4 indexa 4.27 (0.34–13.7) 3.48 (1.19–6.33) 0.80
Fibrosis (F:0–1/2/3/4) (1/21/29/13) (1/15/10/4) 0.91
Inflammation (A:0/1/2/3) (0/7/42/15) (0/5/12/13) 0.24
FibroScan (kPa)a 13.9 (2.5–46.4) 11.9 (5.6–46.4) 0.36
VTQ (m/s)a 1.69 (0.95–3.28) 1.81 (0.89–3.45) 0.41
HCC Stage (I/II/III) (30/25/9) (18/10/2) 0.05
  1. amedian (range)
  2. Plt platelet count, BMI Body Mass Index, Alb albumin, T-Bil total bilirubin, AST aspartate aminotransferase, ALT alanine aminotransferase, M2BPGi Mac-2 binding protein glycosylation isomer, SVR sustained viral response, VTQ Virtual-Touch tissue quantification, HCC hepatocellular carcinoma